SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001193125-10-091461
Filing Date
2010-04-23
Accepted
2010-04-23 14:01:47
Documents
2
Effectiveness Date
2010-04-23

Document Format Files

Seq Description Document Type Size
1 SOLICITING MATERIAL PURSUANT TO 240.14A-12 ddfan14a.htm DFAN14A 24318
2 GRAPHIC g70005g71w51.jpg GRAPHIC 21629
  Complete submission text file 0001193125-10-091461.txt   56240
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 000-15190 | Film No.: 10766827
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 3-11 NIHONBASHI-HONCHO 2-CHOME CHUO-KU TOKYO M0 103-8411
Business Address 3-11 NIHONBASHI-HONCHO 2-CHOME CHUO-KU TOKYO M0 103-8411 81-3-3244-3231
Astellas Pharma Inc. (Filed by) CIK: 0001376684 (see all company filings)

IRS No.: 132971791
Type: DFAN14A